FierceBiotech 2025-12-23 Edwards nets FDA approval for Sapien M3 transcatheter mitral valve replacement
FierceBiotech 2025-12-23 Windtree offloads cardio pipeline, Vaccinex secures $60M funding in continued holiday shopping spree
FierceBiotech 2025-12-23 Despite geopolitical pressures, China biotech deals remain at pace as collective value soars: Evaluate
FierceBiotech 2025-12-23 Hope springs toward Parkinson's phase 3 despite divergent stem cell therapy data
FierceBiotech 2025-12-23 Miracle babies, antibiotic improv and T-cell tamers: Fierce's favorite research stories of 2025
FierceBiotech 2025-12-22 BioMarin quietly discards liver disease candidate after $4.8B Amicus announcement
FierceBiotech 2025-12-22 Boehringer spells out a $448M future for Rectify's ABC kidney disease program
FierceBiotech 2025-12-22 Editor's corner: Fierce Medtech's top 10 stories of 2025 show how tech can treat
FierceBiotech 2025-12-22 AstraZeneca flunks phase 3 lung cancer test in further setback to synthetic lethal mechanism
FierceBiotech 2025-12-20 Looking ahead with BD’s Bilal Muhsin on what good AI can still do for healthcare